Subject: Magnetic Blood Filtration: "The Big Push"

INSIDE THIS NEWSLETTER

  • Series A Fundraising
  • London Tech Week
  • Healthtech Leaders Virtual
  • EIT Health Catapult Semi-Finals
  • Cycle4Sepsis Initiative
  • We Are Hiring
  • Meet our employee
"The Big Push"
Hitting new milestones
Autumn is always a busy time of the year, and we are not expecting anything different here at MediSieve! Over the summer we have continued the work to validate our magnetic bead products, retaining our focus on IL-6 as a target for both Sepsis and COVID-19. We’ve moved forward in leaps and bounds and have some great new data to share with our clinical partners and potential investors. Indeed, we are now approaching investors as we look to complete a Series A over the coming months, so watch this space! We are also looking to add new members to our growing team, so check out the full-time opportunities available and share with your contacts!
Series A Fundraising
We are looking for experienced institutional investors to participate in our Series A, which will support pivotal clinical trials for our anti-IL-6 Magnetic Blood Filtration products. Please get in touch to request more information and a company deck.
Get in touch to get more information: info@medisieve.co.uk
MediSieve Attending Virtual Events
This September we attended several virtual events - London Tech Week and Healthtech Leaders - during which we were able to engage with a vibrant community of innovators and investors from all over the world. In addition, our partners at Upstream provided us with the opportunity to present our technology at the Tech For Impact Showcase (you can watch that on Youtube!). 
Follow us to learn where you can meet us:
https://www.linkedin.com/company/medisieve-limited/

EIT Health Catapult Semi-Finals
Earlier this year we were selected as winners of the regional round of the EIT Health Catapult, a training and competition programme that boosts the development of European health start-ups by exposing them to top-quality experts and international investors. Our founder and CEO, George Frodsham, will be presenting MediSieve at the Biotech pitch event on October 21st.
Register here: https://www.europeanhealthcatapult.eu/register-for-semifinals/
MediSieve Joins the Cycle4Sepsis Campaign
This September we joined the UK Sepsis Trust's initiative Cycle4Sepsis in order to raise vital funds and sepsis awareness. Our team covered a total of 640 miles, outperforming the initial target by 40 miles. We are looking for some special, kind people to sponsor us on the last day of the campaign! 
Support our team and donate here: https://www.justgiving.com/team/MediSieve
We Are Hiring!
We are still on the look out for new talent to join our fantastic team and help us bring our exciting blood filtration technology through clinical trials and into the market. We are looking for highly motivated, engaging and proactive people to join our team as Formulation Scientist-Product Development, Simulation Engineer, and Conjugation Scientist.
Please send your CV and a cover letter explaining what you can bring to MediSieve to jobs@medisieve.co.uk.

MediSieve Faces 
MediSieve is working on creating a novel blood filtration technology that will be the first of its kind. But what truly sets us apart from other companies is our people. Meet the individuals who are transforming our dream of eliminating the burden of blood-borne diseases into reality:
Lucy Moran
Biochemist 
Nationality: Irish
Joined: July 2018

What are your responsibilities within MediSieve?
My main responsibilities are based within the lab team. I am largely involved in the development of the MediSieve Beads, as well as contributing to different components of the sepsis project and being responsible for several lab management functions such as orders and  equipment maintenance. 

What originally drew you to MediSieve?
Having previously worked in a large biopharmaceutical company, I wanted to try working in a start-up where I thought it would be easier to have a bigger impact on the company. Having seen the job advertisement for Medisieve, I was immediately fascinated and excited by the concept and decided it was definitely something I wanted to be part of.  

What do you like most about working here?
I love having such a diverse role and responsibilities and being able to contribute to different projects and tasks. But mainly it is great being part of such a small, diverse and close community where all ideas are welcomed and there is a great overall work atmosphere amongst everyone.

How did the COVID-19 outbreak affect your personal and work life?
As a result of COVID-19, we have had to adapt and implement certain measures in the lab and office in order to ensure we are socially distanced in work. We work from home unless we have experiments to do, to ensure that there are never too many people in the lab or office at once. Although it took a while to get used to, it never really impacted too much on our work and I guess now it has just become the new "normal" and will be for the foreseeable future! Outside of work, I think I adapted relatively well, taking up several new hobbies (including being one of the many people to take up running!). The hardest part though, is definitely being unable to go back and visit my family (and dogs!) in Ireland, as often as I was used to.


"Imagine a world where doctors are able to target and remove infected cells, pathogens, toxins, or even viruses directly from a patient’s bloodstream."
You may unsubscribe or change your contact details at any time.